If you have ever started or titrated an IV nitroglycerin infusion for a cardiac patient, or if you currently work in a setting where an IV nitroglycerin infusion might be ordered, we would sincerely appreciate your participation in a very short, 3-question survey. The Institute for Safe Medication Practices is evaluating two different presentations of the product’s strength as it appears on the label of nitroglycerin bottles. ISMP intends to use the information to inform any recommended changes to the labels.

Please click "next" to begin the survey.

T